Document is current
Any future updates will be listed below
-
Authors
Paolisso, Pasquale
Bergamaschi, Luca
Santulli, Gaetano
Gallinoro, Emanuele
Cesaro, Arturo
Gragnano, Felice
Sardu, Celestino
Mileva, Niya
Foà, Alberto
Armillotta, Matteo
Sansonetti, Angelo
Amicone, Sara
Impellizzeri, Andrea
Casella, Gianni
Mauro, Ciro
Vassilev, Dobrin
Marfella, Raffaele
Calabrò, Paolo
Barbato, Emanuele
Pizzi, Carmine
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct5261867 at ClinicalTrials.govDocuments that mention this clinical trial
Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry
https://doi.org/10.1186/s12933-022-01506-8
- License Information
-
More Information
Article History
Received: 8 March 2022
Accepted: 13 April 2022
First Online: 15 May 2022
Declarations
:
: Data were collected as part of an approved international multicenter observational study. The present study was conducted according to the principles of the Declaration of Helsinki; all patients were informed about their participation in the registry and provided informed consent for the anonymous publication of scientific data.
: Not applicable.
: The authors declare that they have no competing interests.
